Clarus Therapeutics Holdings (Clarus Therapeutics Holdings) Days Payable : 886.70 (As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Clarus Therapeutics Holdings Days Payable?

Clarus Therapeutics Holdings's average Accounts Payable for the three months ended in Jun. 2022 was $11.27 Mil. Clarus Therapeutics Holdings's Cost of Goods Sold for the three months ended in Jun. 2022 was $1.16 Mil. Hence, Clarus Therapeutics Holdings's Days Payable for the three months ended in Jun. 2022 was 886.70.

The historical rank and industry rank for Clarus Therapeutics Holdings's Days Payable or its related term are showing as below:

CRXWQ' s Days Payable Range Over the Past 10 Years
Min: 508.7 Med: 1128.34 Max: 1747.97
Current: 1318.05

During the past 2 years, Clarus Therapeutics Holdings's highest Days Payable was 1747.97. The lowest was 508.70. And the median was 1128.34.

CRXWQ's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 88.69 vs CRXWQ: 1318.05

Clarus Therapeutics Holdings's Days Payable increased from Jun. 2021 (0.00) to Jun. 2022 (886.70). It may suggest that Clarus Therapeutics Holdings delayed paying its suppliers.

Clarus Therapeutics Holdings Days Payable Historical Data

The historical data trend for Clarus Therapeutics Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarus Therapeutics Holdings Days Payable Chart

Clarus Therapeutics Holdings Annual Data

Trend

Dec20

Dec21

Days Payable

508.70

1,747.97

Clarus Therapeutics Holdings Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Days Payable	Get a 7-Day Free Trial			-	2,834.65	1,054.37	1,924.01	886.70

Competitive Comparison of Clarus Therapeutics Holdings's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Clarus Therapeutics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clarus Therapeutics Holdings's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Clarus Therapeutics Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Clarus Therapeutics Holdings's Days Payable falls into.

Clarus Therapeutics Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Clarus Therapeutics Holdings's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (12.107	+	13.945)	/	2 )	/	2.72	*	365
=	13.026					/	2.72	*	365
=	1,747.97

Clarus Therapeutics Holdings's Days Payable for the quarter that ended in Jun. 2022 is calculated as:

	Days Payable (Q: Jun. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2022 )	+	Accounts Payable (Q: Jun. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2022 )	*	Days in Period
=	( (14.056	+	8.488)	/	2 )	/	1.16	*	365 / 4
=	11.272					/	1.16	*	365 / 4
=	886.70

Clarus Therapeutics Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Clarus Therapeutics Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarus Therapeutics Holdings (Clarus Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Clarus Therapeutics Holdings Inc (OTCPK:CRXWQ) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

555 Skokie Boulevard, Suite 340, Northbrook, IL, USA, 60062

Website

https://www.clarustherapeutics.com

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company is focused on focused on the commercialization of JATENZO (testosterone undecanoate), the first and only oral testosterone replacement, or testosterone replacement therapy, and JATENZO is the sole source of company's revenue.